ASX - By Stock
|
TPG |
Re:
What's the go with TPG
|
|
blue30
|
86 |
69K |
3 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
86
|
69K
|
3
|
|
ASX - By Stock
|
TPG |
Re:
Ann: Change of Officers
|
|
blue30
|
67 |
40K |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
67
|
40K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
I am still hearing music - and getting louder
|
|
blue30
|
252 |
105K |
13 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
252
|
105K
|
13
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Becoming a substantial holder
|
|
blue30
|
45 |
15K |
10 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
45
|
15K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
blue30
|
1.4K |
566K |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
1.4K
|
566K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Becoming a substantial holder
|
|
blue30
|
45 |
15K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
45
|
15K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
blue30
|
1.4K |
566K |
0 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
1.4K
|
566K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
blue30
|
1.4K |
566K |
1 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
1.4K
|
566K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
blue30
|
532 |
176K |
9 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
532
|
176K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
blue30
|
532 |
176K |
10 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
532
|
176K
|
10
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Outstanding SubB2M Ovarian Cancer Test Data
|
|
blue30
|
532 |
176K |
28 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
532
|
176K
|
28
|
|
ASX - By Stock
|
IIQ |
Re:
Progress to Further Commercialisation - updates
|
|
blue30
|
60 |
26K |
1 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
60
|
26K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Dr Irminger steps down from Board, continues as Consultant
|
|
blue30
|
16 |
6.5K |
6 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
16
|
6.5K
|
6
|
|
Charts
|
CSL |
Re:
CSL possible pull back to low $200's
|
|
blue30
|
582 |
341K |
8 |
14/01/21 |
14/01/21 |
Charts
|
582
|
341K
|
8
|
|
ASX - By Stock
|
IIQ |
Re:
Progress to Further Commercialisation - updates
|
|
blue30
|
60 |
26K |
8 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
60
|
26K
|
8
|
|
Charts
|
CSL |
Re:
CSL possible pull back to low $200's
|
|
blue30
|
582 |
341K |
10 |
13/01/21 |
13/01/21 |
Charts
|
582
|
341K
|
10
|
|
ASX - By Stock
|
TPG |
Re:
Ann: HY20 Financial Results Commentary
|
|
blue30
|
33 |
23K |
2 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
33
|
23K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Further Detail on BARD1's US Sales Strategy
|
|
blue30
|
16 |
7.7K |
3 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
16
|
7.7K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Trading Halt
|
|
blue30
|
23 |
10K |
1 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Results of Meeting
|
|
blue30
|
13 |
4.7K |
0 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
13
|
4.7K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Results of Meeting
|
|
blue30
|
13 |
4.7K |
1 |
30/11/20 |
30/11/20 |
ASX - By Stock
|
13
|
4.7K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Helen Fisher Steps Down from BARD1 Board
|
|
blue30
|
16 |
5.8K |
2 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
16
|
5.8K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Helen Fisher Steps Down from BARD1 Board
|
|
blue30
|
16 |
5.8K |
0 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
16
|
5.8K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
What are we waiting for?
|
|
blue30
|
26 |
10K |
4 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
What are we waiting for?
|
|
blue30
|
26 |
10K |
6 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
26
|
10K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Gains New High-volume Customer for its hTERT Test
|
|
blue30
|
5 |
2.7K |
2 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
5
|
2.7K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
blue30
|
7 |
4.6K |
14 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
7
|
4.6K
|
14
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
blue30
|
19 |
5.9K |
2 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
19
|
5.9K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Successful BARD1 Kit Evaluation
|
|
blue30
|
90 |
37K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
90
|
37K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Successful BARD1 Kit Evaluation
|
|
blue30
|
90 |
37K |
1 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
90
|
37K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Successful BARD1 Kit Evaluation
|
|
blue30
|
90 |
37K |
3 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
90
|
37K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Successful BARD1 Kit Evaluation
|
|
blue30
|
90 |
37K |
4 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
90
|
37K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Show me the money!
|
|
blue30
|
8 |
3.8K |
2 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
8
|
3.8K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Awarded BTB Funding to Develop Breast Cancer Test
|
|
blue30
|
37 |
15K |
2 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
37
|
15K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Awarded BTB Funding to Develop Breast Cancer Test
|
|
blue30
|
37 |
15K |
2 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
37
|
15K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
blue30
|
39 |
10K |
4 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
blue30
|
39 |
10K |
3 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
39
|
10K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
blue30
|
39 |
10K |
5 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
39
|
10K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 4E and Annual Report to Shareholders
|
|
blue30
|
39 |
10K |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
39
|
10K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
719
|
590K
|
3
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: European Patent Validated
|
|
blue30
|
15 |
7.1K |
9 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
15
|
7.1K
|
9
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
2 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
719
|
590K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
4 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
719
|
590K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Appendix 2A - Issue of Scheme Shares
|
|
blue30
|
9 |
3.8K |
2 |
29/07/20 |
29/07/20 |
ASX - By Stock
|
9
|
3.8K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
4 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
719
|
590K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
0 |
27/07/20 |
27/07/20 |
ASX - By Stock
|
719
|
590K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
1 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
719
|
590K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
0 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
719
|
590K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Chart
|
|
blue30
|
719 |
590K |
7 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
719
|
590K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: SDX: Results of Scheme Meeting
|
|
blue30
|
28 |
7.5K |
8 |
17/07/20 |
17/07/20 |
ASX - By Stock
|
28
|
7.5K
|
8
|
|